Literature DB >> 29627032

Factors associated with distal symmetric polyneuropathies in adult Zambians: A cross-sectional, observational study of the role of HIV, non-antiretroviral medication exposures, and nutrition.

Michelle Kvalsund1, Takondwa Chidumayo2, Johanna Hamel3, David Herrmann4, Douglas Heimburger5, Amanda Peltier6, Gretchen Birbeck7.   

Abstract

BACKGROUND: Non-antiretroviral (ART) drug exposures and poor nutrition may be important modifiable risk factors for distal symmetric polyneuropathies (DSP) in sub-Saharan Africa.
METHODS: We conducted a cross-sectional study of DSP prevalence and factors associated with DSP among clinic attendees in urban and rural Zambia. All participants underwent neurologist-performed examination. Laboratory investigations seeking comorbid risk factors for DSP were performed for DSP cases.
RESULTS: We identified 31/137 (22.6%) HIV+ and 21/177 (11.9%) HIV- DSP cases. DSP prevalence did not differ by urbanicity, although rural participants were significantly more likely to have one asymptomatic DSP sign. Low dietary diversity, history of syphilis, history of tuberculosis, and prior metronidazole and ciprofloxacin use were associated with DSP amongst HIV+ cases, while age and education were associated with DSP in HIV- participants (all p-values < 0·05). In a multivariate logistic regression model, HIV (p = 0·0001) and age (p < 0·0001), and ciprofloxacin exposure (p = 0·01) remained independently associated with DSP. While diabetes was rare, supoptimal micronutrients levels were common among DSP cases regardless of HIV status.
CONCLUSIONS: While HIV infection is strongly associated with DSP in Zambia, history of non-ART drug exposures and low dietary diversity are also important determinants of DSP in HIV+ individuals. Treatable micronutrient deficiencies were common.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Africa; Epidemiology; HIV; Neuropathy; Nutrition

Mesh:

Substances:

Year:  2018        PMID: 29627032      PMCID: PMC5971194          DOI: 10.1016/j.jns.2018.02.035

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  44 in total

Review 1.  Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

Authors:  J D England; G S Gronseth; G Franklin; R G Miller; A K Asbury; G T Carter; J A Cohen; M A Fisher; J F Howard; L J Kinsella; N Latov; R A Lewis; P A Low; A J Sumner
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

Review 2.  The developmental origins of adult disease (Barker) hypothesis.

Authors:  Hendrina A de Boo; Jane E Harding
Journal:  Aust N Z J Obstet Gynaecol       Date:  2006-02       Impact factor: 2.100

3.  Evaluation of a clinical screening tool for HIV-associated sensory neuropathies.

Authors:  Catherine L Cherry; Steven L Wesselingh; Luxshimi Lal; Justin C McArthur
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

Review 4.  Manifestations of HIV infection in the peripheral nervous system.

Authors:  Chad M Centner; Kathleen J Bateman; Jeannine M Heckmann
Journal:  Lancet Neurol       Date:  2013-03       Impact factor: 44.182

5.  Peripheral neuropathy in HIV: prevalence and risk factors.

Authors:  Scott R Evans; Ronald J Ellis; Huichao Chen; Tzu-min Yeh; Anthony J Lee; Giovanni Schifitto; Kunling Wu; Ronald J Bosch; Justin C McArthur; David M Simpson; David B Clifford
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

Review 6.  Epidemiology of polyneuropathy in diabetes and prediabetes.

Authors:  Dan Ziegler; Nikolaos Papanas; Aaron I Vinik; Jonathan E Shaw
Journal:  Handb Clin Neurol       Date:  2014

7.  Association of Child Poverty, Brain Development, and Academic Achievement.

Authors:  Nicole L Hair; Jamie L Hanson; Barbara L Wolfe; Seth D Pollak
Journal:  JAMA Pediatr       Date:  2015-09       Impact factor: 16.193

8.  Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh.

Authors:  Kjersti Mørkrid; Liaquat Ali; Akhtar Hussain
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

Review 9.  Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature.

Authors:  Tiffany A Goolsby; Bernadette Jakeman; Robert P Gaynes
Journal:  Int J Antimicrob Agents       Date:  2017-09-05       Impact factor: 5.283

10.  Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing.

Authors:  Deanna Cettomai; Judith Kwasa; Caroline Kendi; Gretchen L Birbeck; Richard W Price; Elizabeth A Bukusi; Craig R Cohen; Ana-Claire Meyer
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

View more
  2 in total

1.  Evaluation of a screening tool for the identification of neurological disorders in rural Uganda.

Authors:  Andy Tran; Kiran T Thakur; Noeline Nakasujja; Gertrude Nakigozi; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Ronald H Gray; Maria J Wawer; Leah H Rubin; Ned Sacktor; Deanna Saylor
Journal:  J Neurol Sci       Date:  2020-12-24       Impact factor: 3.181

2.  Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

Authors:  Alyssa C Vecchio; Christina M Marra; Jeffrey Schouten; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; James Hakim; Ned Sacktor; Thomas B Campbell; Srikanth Tripathy; Nagalingeswaran Kumarasamy; Alberto La Rosa; Breno Santos; Marcus T Silva; Cecilia Kanyama; Cindy Firnhaber; Mina C Hosseinipour; Rosie Mngqibisa; Colin Hall; Paola Cinque; Kevin Robertson
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.